[5]
Ong, H.C.; Mojiun, P.F.J.; Milow, P. Traditional knowledge of edible plants among the Temuan villagers in Kampung Guntor, Negeri Sembilan, Malaysia. Afr. J. Agric. Res., 2011, 6(8), 1962-1965.
[8]
Lévi, S.; Przyluski, J.; Bloch, J. Die Turzismen in der Sprache der Kroaten und Serben; Calcutta, 1929.
[14]
Parks, S. et al., Assessing the Potential for a Gac (Cochinchin gourd) Industry in Australia. , 2013. Australia..
[21]
Vuong, L.T. Momordica cochinchinensis (Spreng.) bcarotene
and method; United States Patent 2004.
[31]
Guichard, F.; Bui, D.S. La matiere colorante du fruit du Momordica cochinchinnensis spreng Annales de l’ecole Superieure de Medecine et de Pharmacie de l’Indochine, 1941, 5, 141-142.
[33]
Kha, T.C. Effects of different drying processes on the phys-icochemical and antioxidant properties of gac fruit powder,
The University of Newcastle: Newcastle, Australia , 2010.
[34]
Ngan, N.T.K.; Hung, N.; Huynh, T.M. Phong chong ung thu gan (Liver cancer prevention). Y Hoc Viet Nam, 1993, 5(171), 81-88.
[53]
Cao Hoang, L.; Waché, Y. Carotene dispersion in liquid media.Beta-Carotene; Dietary Sources, C; Cognition, L.H.T.B., Ed.; Novapublishers: Hauppauge, NY, 2009, pp. 283-298.
[54]
Vo, V-C., Ed.; A Dictionary of Medicinal Plants of Vietnam; Ho-Chi-Minh City, 2007.
[57]
AREDS_Research_Group, A Randomized, Placebo-
Controlled, Clinical Trial of High-Dose Supplementation
With Vitamins C and E, Beta Carotene, and Zinc for Age-
Related Macular Degeneration and Vision Loss: AREDS
Report No. 8, A.o. Ophthalmology, Editor. 2001, National
Institutes of Health: Rockville; , 2001.
[60]
Scripsema, N.K.; Hu, D-N.; Rosen, R.B. Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease. J.of Ophthalmol., 2015.
[62]
Li, W. Anti-inflammatory effects of lycopene prevents cardiac dysfunction in streptozotocin-diabetic rats. Int. J. Clin. Exp. Med., 2016, 9(5), 8047-8054.
[65]
Uteshev, D. The anti-inflammatory activity of intal and beta-carotene in a model of experimental granulomatous lung inflammation. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya, 2000, 2, 19-22.
[77]
Report of a Joint WHO/FAO Expert Consultation, in WHO
Technical Report Series 916. 2003; World Health Organization:
Geneva, 2003, 88.
[78]
Couet, C. Acides gras de la famille oméga 3 et système
cardiovaculaire: intérêt nutritionnel et allégations; Afssa,
Editor: Paris , 2001.
[79]
Martin, A. Apports nutritionnels conseillés pour la population française 3ème édition; Edition TECandDOC Lavoisier ed.: Paris, 2001.
[83]
Le Grusse, J. Les vitamines, données biochimiques, nutritionnelles et cliniques; Neuilly sur Seine: CEIV - Produits Roche. , 1993.
[84]
Vassiliou, A. Authorising the placing on the market of lycopene
as novel food ingredient under Regulation (EC) No
258/97 of the European Parliament and of the Council, in
C(2009) 3149, T.C.o.t.E. Communities; Official Journal of
the European Union: Brussels, , 2009.
[85]
Briand, P. Avis de l’Agence française de sécurité sanitaire des aliments relatif à l’évaluation des risques éventuels liés à l’emploi de lycopène en tant qu’ingrédient alimentaire, Afssa; Maisons-Alfort, 2005.
[89]
d’Enfert, V. The Nagoya Protocol imposes new rules, in
Expression Cosmétique. The global information on cosmetics
and fragrances; , 2013.
[92]
Minh, N.P.; Dao, D.T.A. Effect of different antioxidant ratios supplemented into mixture of Gac (Momordica cochinchinensis Spreng) seed membrane-carrier to total carotene; accelerated temperature to shelf-life of Gac powder. Int. J. Eng. Res. Technol. (Ahmedabad), 2013, 2(11), 1005-1018.